Utama › Glioma › North Carolina › Durham
Kajian klinikal Glioma di Durham, NC
12 kajian untuk Glioma sedang mencari peserta di lokasi dalam dan sekitar Durham (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Mengambil pesertaFasa 2
- Duke University Medical Center, Durham
Targeted Pediatric High-Grade Glioma Therapy
Mengambil pesertaKajian pemerhatian
- Duke University Health System, Durham
Study of Olutasidenib and Temozolomide in HGG
Mengambil pesertaFasa 2
- Duke University Health System, Durham
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Mengambil pesertaFasa 3
- Duke Cancer Institute, Durham
ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas
Mengambil pesertaFasa 1
- Duke University Medical Center, Durham
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
Mengambil pesertaFasa 2
- Duke Cancer Center, Durham
Lerapolturev (PVSRIPO) in GBM
Mengambil pesertaFasa 2
- Duke University Medical Center, Durham
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Mengambil pesertaFasa awal 1Sukarelawan sihat dialu-alukan
- Duke University Health System, Durham
Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma
Mengambil pesertaFasa 1
- Duke University Medical Center, Durham
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Mengambil pesertaFasa 2
- Duke University Health System, Durham
Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252
Mengambil pesertaFasa 1
- Duke University, Durham
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
Mengambil pesertaFasa awal 1
- Duke University Health System, Durham
Kajian Glioma di bandar lain
- New York City, NY25 kajian
- Houston, TX23 kajian
- Boston, MA20 kajian
- Washington, DC19 kajian
- Philadelphia, PA16 kajian
- Columbus, OH15 kajian
- Miami, FL15 kajian
- San Francisco, CA14 kajian
- Chicago, IL13 kajian
- Seattle, WA11 kajian
- St. Louis, MO10 kajian
- Aurora, CO10 kajian
Kajian lain di Durham
- Kanser Payudara64 kajian
- Kanser (semua jenis)58 kajian
- Kanser Paru-paru Bukan Sel Kecil39 kajian
- Mieloma Pelbagai37 kajian
- Leukemia Mieloid Akut33 kajian
- Kanser Metastatik33 kajian
- Kanser Prostat32 kajian
- Kanser Paru-paru32 kajian
- Kanser Kolorektal28 kajian
- Kanser Ovari27 kajian
- Leukemia Limfositik Kronik27 kajian
- Kegagalan Jantung26 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.